首页> 外文期刊>Revista Brasileira de Terapia Intensiva >Prognostics factors for mortality and renal recovery in critically ill patients with acute kidney injury and renal replacement therapy
【24h】

Prognostics factors for mortality and renal recovery in critically ill patients with acute kidney injury and renal replacement therapy

机译:重症急性肾损伤患者的死亡率和肾脏恢复的预后因素及肾脏替代治疗

获取原文

摘要

Objective: Identify prognostic factors related to mortality and non-recovery of renal function. Methods: A prospective single-center study was conducted at the intensive care medicine department of a university hospital between 2012 and 2015. Patients with acute kidney injury receiving continuous renal replacement therapy were included in the study. Clinical and analytical parameters were collected, and the reasons for initiation and discontinuation of renal replacement therapy were examined. Results: A total of 41 patients were included in the study, of whom 43.9% had sepsis. The median Simplified Acute Physiology Score II (SAPSII) was 56 and the mortality was 53.7%, with a predicted mortality of 59.8%. The etiology of acute kidney injury was often multifactorial (56.1%). Survivors had lower cumulative fluid balance (median = 3,600mL, interquartile range [IQR] = 1,175 - 8,025) than non-survivors (median = 12,000mL, IQR = 6,625 - 17,875; p = 0.004). Patients who recovered renal function (median = 51.0, IQR = 45.8 - 56.2) had lower SAPS II than those who do not recover renal function (median = 73, IQR = 54 - 85; p = 0.005) as well as lower fluid balance (median = 3,850, IQR = 1,425 - 8,025 versus median = 11,500, IQR = 6,625 - 16,275; p = 0.004). Conclusions: SAPS II at admission and cumulative fluid balance during renal support therapy were risk factors for mortality and non-recovery of renal function among critically ill patients with acute kidney injury needing renal replacement therapy.
机译:目的:确定与死亡率和肾功能未恢复有关的预后因素。方法:2012年至2015年间,在大学医院的重症监护室进行了一项前瞻性单中心研究。该研究包括接受连续性肾脏替代治疗的急性肾损伤患者。收集临床和分析参数,并检查开始和终止肾脏替代治疗的原因。结果:总共41例患者被纳入研究,其中43.9%患有败血症。简易急性生理评分II(SAPSII)的中位数为56,死亡率为53.7%,预计死亡率为59.8%。急性肾损伤的病因通常是多因素的(56.1%)。幸存者的累积体液平衡较低(中位数= 3,600mL,四分位间距[IQR] = 1,175-8,025)比非幸存者(中位数= 12,000mL,IQR = 6,625-17,875; p = 0.004)低。恢复肾功能的患者(中位数= 51.0,IQR = 45.8-56.2)的SAPS II低于未恢复肾功能的患者(中位数= 73,IQR = 54-85; p = 0.005)以及体液平衡降低(中位数= 3,850,IQR = 1,425-8,025,而中位数= 11,500,IQR = 6,625-16,275; p = 0.004)。结论:肾支持治疗期间入院时的SAPS II和累积体液平衡是需要肾脏替代治疗的重症急性肾损伤患者中死亡和肾功能未恢复的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号